Surgical Injury and Ischemia Prime the Adipose Stromal Vascular Fraction and Increase Angiogenic Capacity in a Mouse Limb Ischemia Model.


Journal

Stem cells international
ISSN: 1687-966X
Titre abrégé: Stem Cells Int
Pays: United States
ID NLM: 101535822

Informations de publication

Date de publication:
2020
Historique:
received: 27 08 2019
revised: 29 02 2020
accepted: 26 03 2020
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 9 6 2020
Statut: epublish

Résumé

The adipose-derived stromal vascular fraction (SVF) is an effective source for autologous cell transplantation. However, the quality and quantity of SVFs vary depending on the patient's age, complications, and other factors. In this study, we developed a method to reproducibly increase the cell number and improve the quality of adipose-derived SVFs by surgical procedures, which we term "wound repair priming." Subcutaneous fat from the inguinal region of BALB/c mice was surgically processed (primed) by mincing adipose parenchyma (injury) and ligating the subcutaneous fat-feeding artery (ischemia). SVFs were isolated on day 0, 1, 3, 5, or 7 after the priming procedures. Gene expression levels of the primed SVFs were measured via microarray and pathway analyses which were performed for differentially expressed genes. Changes in cellular compositions of primed SVFs were analyzed by flow cytometry. SVFs were transplanted into syngeneic ischemic hindlimbs to measure their angiogenic and regeneration potential. Hindlimb blood flow was measured using a laser Doppler blood perfusion imager, and capillary density was quantified by CD31 staining of ischemic tissues. Stabilization of HIF-1 alpha and VEGF-A synthesis in the SVFs were measured by fluorescent immunostaining and Western blotting, respectively. As a result, the number of SVFs per fat weight was increased significantly on day 7 after priming. Among the differentially expressed genes were innate immunity-related signals on both days 1 and 3 after priming. In primed SVFs, the CD45-positive blood mononuclear cell fraction decreased, and the CD31-CD45-double negative mesenchymal cell fraction increased on day 7. The F4/80-positive macrophage fraction was increased on days 1 and 7 after priming. There was a serial decrease in the mesenchymal-gated CD34-positive adipose progenitor fraction and mesenchymal-gated CD140A-positive/CD9-positive preadipocyte fraction on days 1 and 3. Transplantation of primed SVFs resulted in increased capillary density and augmented blood flow, improving regeneration of the ischemic limbs. HIF-1 alpha was stabilized in the primed cutaneous fat

Identifiants

pubmed: 32508933
doi: 10.1155/2020/7219149
pmc: PMC7251464
doi:

Types de publication

Journal Article

Langues

eng

Pagination

7219149

Informations de copyright

Copyright © 2020 Satoko Kishimoto et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Références

Lab Invest. 1990 Dec;63(6):832-40
pubmed: 2255190
Circulation. 2004 Feb 10;109(5):656-63
pubmed: 14734516
Biochem Biophys Res Commun. 2006 Mar 17;341(3):864-73
pubmed: 16455057
Cytotherapy. 2013 Jun;15(6):641-8
pubmed: 23570660
Stem Cell Res Ther. 2014 Jun 18;5(3):79
pubmed: 24943716
Eur J Clin Invest. 2011 Feb;41(2):126-33
pubmed: 20874854
Am J Pathol. 1998 Jun;152(6):1667-79
pubmed: 9626071
Nat Rev Immunol. 2010 Dec;10(12):826-37
pubmed: 21088683
J Transl Med. 2007 Oct 31;5:55
pubmed: 17974012
Atherosclerosis. 2016 Jun;249:132-9
pubmed: 27100923
Tissue Eng Part A. 2012 Nov;18(21-22):2239-47
pubmed: 22655590
Ann Plast Surg. 2008 May;60(5):538-44
pubmed: 18434829
Vet Ther. 2007 Winter;8(4):272-84
pubmed: 18183546
Am J Transplant. 2016 Dec;16(12):3338-3361
pubmed: 27421829
Int J Biol Sci. 2014 May 01;10(5):520-9
pubmed: 24910531
J Tissue Eng. 2011;2011:158105
pubmed: 21772956
Cell Stem Cell. 2013 Oct 3;13(4):392-402
pubmed: 24094322
Circ J. 2012;76(7):1750-60
pubmed: 22498564
Am J Pathol. 1990 Jul;137(1):85-92
pubmed: 1695484
Wound Repair Regen. 2007 Jul-Aug;15(4):511-20
pubmed: 17650095
Diabetes. 2009 Nov;58(11):2574-82
pubmed: 19690061
Cell Metab. 2017 Mar 7;25(3):673-685
pubmed: 28215843
J Biomed Mater Res A. 2010 Mar 15;92(4):1614-22
pubmed: 19437440
Curr Opin Lipidol. 2011 Oct;22(5):365-72
pubmed: 21825981
Science. 2018 Nov 23;362(6417):
pubmed: 30467144
J Tissue Eng Regen Med. 2009 Jun;3(4):290-301
pubmed: 19309766

Auteurs

Satoko Kishimoto (S)

Comprehensive Research Facilities for Advanced Medical Science, Research Center for Advanced Medical Science, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan.

Ken-Ichi Inoue (KI)

Comprehensive Research Facilities for Advanced Medical Science, Research Center for Advanced Medical Science, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan.
Center of Regenerative Medicine, Dokkyo Medical University Hospital, Mibu, Tochigi 321-0293, Japan.

Ryoichi Sohma (R)

Comprehensive Research Facilities for Advanced Medical Science, Research Center for Advanced Medical Science, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan.

Shigeru Toyoda (S)

Center of Regenerative Medicine, Dokkyo Medical University Hospital, Mibu, Tochigi 321-0293, Japan.
Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan.

Masashi Sakuma (M)

Center of Regenerative Medicine, Dokkyo Medical University Hospital, Mibu, Tochigi 321-0293, Japan.
Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan.

Teruo Inoue (T)

Comprehensive Research Facilities for Advanced Medical Science, Research Center for Advanced Medical Science, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan.
Center of Regenerative Medicine, Dokkyo Medical University Hospital, Mibu, Tochigi 321-0293, Japan.
Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan.

Ken-Ichiro Yoshida (KI)

Comprehensive Research Facilities for Advanced Medical Science, Research Center for Advanced Medical Science, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan.
Center of Regenerative Medicine, Dokkyo Medical University Hospital, Mibu, Tochigi 321-0293, Japan.

Classifications MeSH